Literature DB >> 32557797

Divergent Siglec-F(eights) of mouse and human eosinophil death.

Elizabeth A Jacobsen1.   

Abstract

Discussion on the differences between mouse and human eosinophil induced death by antibody ligation to human Siglec-8 and mouse Siglec-F. ©2020 Society for Leukocyte Biology.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32557797      PMCID： PMC7528932          DOI： 10.1002/JLB.5CE0520-108R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN： 0741-5400            Impact factor:   4.962


  12 in total

1.  IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils.

Authors:  Ho Jeong Na; Sherry A Hudson; Bruce S Bochner
Journal:  Cytokine       Date:  2011-11-12       Impact factor: 3.861

2.  Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls.

Authors:  Eva Knuplez; Rebecca Krier-Burris; Yun Cao; Gunther Marsche; Jeremy O'Sullivan; Bruce S Bochner
Journal:  J Leukoc Biol       Date:  2020-03-05       Impact factor: 4.962

Review 3.  Siglec-mediated regulation of immune cell function in disease.

Authors:  Matthew S Macauley; Paul R Crocker; James C Paulson
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

4.  Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.

Authors:  Fanny Legrand; Yun Cao; Joshua B Wechsler; Xiang Zhu; Nives Zimmermann; Shakuntala Rampertaap; Joseph Monsale; Kimberly Romito; Bradford A Youngblood; Emily C Brock; Michelle A Makiya; Nenad Tomasevic; Christopher Bebbington; Irina Maric; Dean D Metcalfe; Bruce S Bochner; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2018-12-10       Impact factor: 10.793

5.  Eosinophils are required for the maintenance of plasma cells in the bone marrow.

Authors:  Van Trung Chu; Anja Fröhlich; Gudrun Steinhauser; Tobias Scheel; Toralf Roch; Simon Fillatreau; James J Lee; Max Löhning; Claudia Berek
Journal:  Nat Immunol       Date:  2011-01-09       Impact factor: 25.606

6.  A Sulfonamide Sialoside Analogue for Targeting Siglec-8 and -F on Immune Cells.

Authors:  Corwin M Nycholat; Shiteng Duan; Eva Knuplez; Charli Worth; Mila Elich; Anzhi Yao; Jeremy O'Sullivan; Ryan McBride; Yadong Wei; Steve M Fernandes; Zhou Zhu; Ronald L Schnaar; Bruce S Bochner; James C Paulson
Journal:  J Am Chem Soc       Date:  2019-08-30       Impact factor: 15.419

7.  Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis.

Authors:  Eitan Rubinstein; Jae Youn Cho; Peter Rosenthal; James Chao; Marina Miller; Alexa Pham; Seema S Aceves; Ajit Varki; David H Broide
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-10       Impact factor: 2.839

8.  Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils.

Authors:  N Zimmermann; M L McBride; Y Yamada; S A Hudson; C Jones; K D Cromie; P R Crocker; M E Rothenberg; B S Bochner
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

9.  Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen.

Authors:  Hui Mao; Gen Kano; Sherry A Hudson; Mary Brummet; Nives Zimmermann; Zhou Zhu; Bruce S Bochner
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

Review 10.  Eosinophils: changing perspectives in health and disease.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Paul S Foster
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.